United States · FDA National Drug Code directory
Clonidine hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 76420-285_e8c7a94e-8d26-886a-e053-2995a90a1ad8
- Product NDC
- 76420-285
- Form
- TABLET
- Composition / generic term
- Clonidine hydrochloride
- Labeler
- Asclemed USA, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20170601
- Source listing expiry
- 20261231
Source-listed ingredients
- CLONIDINE HYDROCHLORIDE — .2 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (76420-285-01) · 76420-285-01
- 20 TABLET in 1 BOTTLE (76420-285-20) · 76420-285-20
- 30 TABLET in 1 BOTTLE (76420-285-30) · 76420-285-30
- 60 TABLET in 1 BOTTLE (76420-285-60) · 76420-285-60
- 90 TABLET in 1 BOTTLE (76420-285-90) · 76420-285-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →